显微下肢重建术后ERAS路径的逐步实施:加速康复且结局稳定
本研究回顾性分析2020年1月至2024年2月连续下肢游离皮瓣重建病例,术后管理逐步向早期康复过渡,分为ERAS前、过渡和ERAS三组。ERAS组术后第1天晨恢复经口进食、当日下午开始轮椅辅助下地活动,目标术后第5天出院。完全实施后中位禁食时间从24.9小时降至12.7小时,卧床时间从4.0天降至1.0天,住院时间从11.5天降至7.0天,皮瓣及供区并发症率随时间显著下降。多变量分析显示ERAS实施与更短禁食时间和卧床时间相关,未增加皮瓣相关并发症。
要点
- ERAS方案在显微下肢重建中可行,促进早期恢复且不增加并发症风险。
- 完全实施后中位禁食时间从24.9小时降至12.7小时,卧床时间从4.0天降至1.0天。
- 住院时间从11.5天降至7.0天,皮瓣及供区并发症率随时间显著下降。
核心结论
- 显微下肢重建中逐步实施ERAS方案可能可行且有效,促进早期恢复而不增加并发症风险。
研究设计与样本
- 回顾性综述2020年1月至2024年2月连续下肢游离皮瓣重建病例,共240个皮瓣、224例患者,分为ERAS前66例、过渡123例、ERAS51例。
主要发现
- 完全实施ERAS后中位禁食时间从24.9小时降至12.7小时,卧床时间从4.0天降至1.0天,住院时间从11.5天降至7.0天。
- 皮瓣及供区并发症率随时间显著下降。
- 多变量分析显示ERAS实施与更短禁食时间和卧床时间相关,未增加皮瓣相关并发症。
- ERAS实施相关的住院时间缩短在ASA分级<3或肿瘤重建患者中尤为明显。
临床怎么用
- ERAS组术后第1天晨恢复经口进食,当日下午开始轮椅辅助下地活动,目标术后第5天出院。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite increasing emphasis on early postoperative recovery, lower extremity microsurgical reconstruction has been overlooked, likely due to concerns of high complication rates and the challenges of a gravity-dependent, weight-bearing region. This study evaluated the feasibility and outcomes of stepwise ERAS protocol implementation in this setting. METHODS: A retrospective review was conducted of consecutive lower extremity free flap reconstructions from January 2020 to February 2024, during which postoperative management evolved stepwise toward early recovery. Patients were categorized into three cohorts-pre-ERAS, transition, and ERAS. In the ERAS cohort, oral intake resumed on POD 1 morning, wheelchair-assisted ambulation began that afternoon, and discharge was targeted for POD 5. Postoperative course and complication rates were compared, and the independent association of ERAS implementation was assessed. RESULTS: In total, 240 flaps in 224 patients were included: 66 pre-ERAS, 123 transition, and 51 ERAS. Following full protocol adoption, median nil per os (NPO) duration decreased from 24.9 to 12.7 hours, bed rest from 4.0 to 1.0 day, and length of stay (LOS) from 11.5 to 7.0 days. Flap- and donor-site complication rates also declined significantly over time. On multivariable analysis, ERAS implementation was associated with shorter NPO duration and reduced bed rest, without an increase in flap-related complications. The reduction in LOS associated with ERAS implementation was particularly pronounced in patients with ASA class <3 or those undergoing oncologic reconstruction. CONCLUSION: Stepwise adoption of an ERAS-based protocol in microsurgical lower extremity reconstruction might be feasible and effective, promoting early recovery without increasing complication risk.
引用
- Bae J, Choi Y, Lee KT, et al. Stepwise Adoption of a Postoperative ERAS Pathway in Microsurgical Lower Extremity Reconstruction: Faster Recovery and Stable Outcomes. Plast Reconstr Surg. 2026. PMID: 41805732. doi:10.1097/PRS.0000000000013001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。